sutezolid
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Rifampin (RIF) plus clarithromycin (CLR) for 8 weeks is now the standard of care for Buruli ulcer (BU) treatment, but CLR may not…
Despite over a century of drug development research, tuberculosis remains a major public health problem with a leading cause of…
Zusammenfassung Dieser Artikel gibt einen kurzen Überblick über den Entwicklungsstand neuer Medikamente zur Therapie der…
This article summarizes the state of development of new drugs for the treatment of multidrug-resistant tuberculosis. We focused…
Purpose of review Recent advances in the development of new drugs and regimens provide hope that well tolerated, effective, and…
Sutezolid is a linezolid analogue with good in vitro activity against Mycobacterium tuberculosis (MTb). Because it does not…